TNFSF10 and breast cancer: Our result suggested that thymoquinonein combination with TRAIL may be a therapeutic agent against MCF-7 and MDA-MB-231 breast cancer cells, which may be get attention in near future as a breakthrough in the treatment of breast cancer patients.